Therapy to Obese Type 2 Diabetes Mellitus:How Far Will We Go Down the Wrong Road?

被引:0
|
作者
HENG Xianpei [1 ]
LI Xiujun [2 ]
LI Liang [1 ]
YANG Liuqing [1 ]
WANG Zita [1 ]
HUANG Suping [3 ]
机构
[1] 不详
[2] Department of Endocrinology, People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
[3] 不详
[4] West China Medical Center of Sichuan Medical University West China University of Medical Science
[5] Academy of Integrative Medicine Fujian, Fujian University of Traditional Chinese Medicine
[6] 不详
关键词
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
摘要
Traditional glucose-lowering chemical agents, including various types of insulin and insulin secretagogues, insulin sensitizers, gliptins, etc., are based on diabetic pathogenesis of insulin resistance(IR) and islet insufficiency. Numerous evidence-based medical studies have shown that these traditional hypoglycemic chemical agents do not provide cardiovascular benefit to patients with type 2 diabetes mellitus(T2 DM) and may even increase the risk of all-cause mortality. Based on research evidence published to date, these studies show that overload of energy could increase the incidence and prevalence of T2 DM, and reduction in the heat load can significantly reduce the incidence of T2 DM. Therefore, the essence of T2 DM is heat overload, meaning heat overload is the etiology of obese T2 DM. At the same time, results of numerous studies show that heat overloading is the cause of IR. IR and islet dysfunction are protective factors in intervening with heat overload.These drugs, which are based on the mechanisms of IR and islet insufficiency, increase caloric reserve and cause or worsen obesity, which is equivalent to exacerbating the basic etiology and the cardiovascular risk factor of T2 DM. Thus, a reasonable strategy for prevention and treatment of obese T2 DM appears to promote the negative balance of calories and the elimination of caloric reserves. Chinese herbal medicines can promote negative balance of heat in many aspects, which can bring new hope for prevention and treatment of T2 DM.
引用
收藏
页码:62 / 71
页数:10
相关论文
共 50 条
  • [1] Therapy to Obese Type 2 Diabetes Mellitus:How Far Will We Go Down the Wrong Road?
    HENG Xian-pei
    LI Xiu-jun
    LI Liang
    YANG Liu-qing
    WANG Zi-ta
    HUANG Su-ping
    Chinese Journal of Integrative Medicine, 2020, 26 (01) : 62 - 71
  • [2] Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road?
    Heng, Xian-pei
    Li, Xiu-jun
    Li, Liang
    Yang, Liu-qing
    Wang, Zi-ta
    Huang, Su-ping
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (01) : 62 - 71
  • [3] Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road?
    Xian-pei Heng
    Xiu-jun Li
    Liang Li
    Liu-qing Yang
    Zi-ta Wang
    Su-ping Huang
    Chinese Journal of Integrative Medicine, 2020, 26 : 62 - 71
  • [4] HOW FAR HAVE WE TRAVELED DOWN HAYEK ROAD
    ARMEY, D
    FORBES, MS
    FRIEDMAN, M
    GRAMM, P
    POSTREL, V
    ROBACK, J
    SHELTON, J
    SMITH, FL
    POLICY REVIEW, 1994, (69) : 14 - 21
  • [5] Type 2 Diabetes Prevention Programs; How Far are we?
    Matte, Margarita E.
    Velonakis, Emmanuel G.
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (11)
  • [6] Major road tunnel projects - How far can we go?
    Marec, M
    TUNNELLING AND UNDERGROUND SPACE TECHNOLOGY, 1996, 11 (01) : 21 - 26
  • [7] How to Screen Obese Children at Risk for Type 2 Diabetes Mellitus?
    van der Aa, Marloes P.
    Farsani, Soulmaz Fazeli
    Kromwijk, Lisa A. J.
    de Boer, Anthonius
    Knibbe, Catherijne A. J.
    van der Vorst, Marja M. J.
    CLINICAL PEDIATRICS, 2014, 53 (04) : 337 - 342
  • [8] Changing trends in epidemiology of type 1 diabetes mellitus throughout the world: how far have we come and where do we go from here
    Libman, IM
    LaPorte, RE
    PEDIATRIC DIABETES, 2005, 6 (03) : 119 - 121
  • [9] Longitudinal Strain and Type 1 Diabetes Mellitus: Are We on the Wrong Track?
    Tadic, Marijana
    Cuspidi, Cesare
    JACC-CARDIOVASCULAR IMAGING, 2015, 8 (11) : 1345 - 1346
  • [10] Type I, Type II, and Occasionally Type III How Can We Go Wrong?
    Maltenfort, Mitchell
    JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2015, 28 (05): : 189 - 189